Physician

Ana Kumar, M.D.

According to 2025 Medicare claims, Ana Kumar, M.D. (NPI: 1215905971) practices rheumatology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is OKLAHOMA ARTHRITIS CENTER, P.C. (NPI: 1528036019; TIN: 731578116) and primary practice location at 73013-3084.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 839 traditional Medicare patients, billed 287,370 HCPCS/CPT codes, and received $3,794,694 in Medicare payments. The top billing code was 96375 (Injection of additional new drug or substance into vein). Part D data shows 4,735 prescription claims across 343 beneficiaries totaling $1,446,319 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 12 claims. Open Payments data shows 7 records totaling $209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,905,381 to $3,794,694. Similarly, Part D prescription costs have risen steadily, from $683,766 to $1,446,319. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,718 and ending at $18,992.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	722	100,544	$1,905,381
2016	920	119,785	$2,353,635
2017	719	89,127	$1,935,969
2018	462	25,742	$573,430
2019	536	38,628	$771,966
2020	976	254,421	$4,819,347
2021	941	307,690	$5,430,598
2022	906	274,180	$4,570,407
2023	911	309,921	$4,244,666
2024	839	287,370	$3,794,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	435	5,111	$683,766
2016	484	5,186	$713,574
2017	367	4,224	$631,243
2018	287	4,100	$845,152
2019	306	3,851	$813,101
2020	518	4,976	$848,512
2021	380	4,751	$821,598
2022	331	4,294	$1,054,756
2023	316	4,318	$1,175,212
2024	343	4,735	$1,446,319

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$712
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$688
2020	N/R	N/R	N/R
2021	N/R	20	$2,644
2022	N/R	12	$323
2023	N/R	N/R	N/R
2024	N/R	12	$904

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96375	Injection of additional new drug or substance into vein	398	1,573	$11
80053	Blood test, comprehensive group of blood chemicals	394	659	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	383	646	$7
86140	Measurement c-reactive protein for detection of infection or inflammation	381	629	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	373	624	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	47	1,408	$368,088
Humira(Cf) Pen	Adalimumab	40	1,096	$272,154
Xeljanz Xr	Tofacitinib Citrate	39	1,170	$220,836
Humira(Cf)	Adalimumab	17	476	$117,305
Benlysta	Belimumab	14	392	$51,406

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	12	$904

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$209	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ana Kumar, M.D.?

Tedicare shows public-source Medicare data for Ana Kumar, M.D. (NPI 1215905971), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ana Kumar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ana Kumar, M.D.?

Ana Kumar, M.D. is linked to OKLAHOMA ARTHRITIS CENTER, P.C. (billing NPI 1528036019) in the available physician profile data.

Does Ana Kumar, M.D. have Open Payments data?

Ana Kumar, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.